Association of ATP synthase α-chain with neurofibrillary degeneration in Alzheimer's disease

Neuroscience

Volumn 117, Issue 2, 2003, Pages 293-303

  Sergeant, N ^a   Wattez, A ^a   Galvan Valencia M ^b   Ghestem, A ^a   David, J P ^a   Lemoine, J ^c   Sautiere P E ^d   Dachary, J ^a   Mazat, J P ^a   Michalski, J C ^c   Velours, J ^e   Mena Lopez R ^b   Delacourte, A ^a  

^a INSERM   (France)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^d Lab d'Endocrinol des Annelides   (France)

^e Institut de Biochimie et Genetique Cellulaires   (France)

Author keywords

Microtubule associated tau protein; Neurodegeneration; Neurofibrillary tangle; Oxidative phosphorylation; Paired helical filament; Proteomic

Indexed keywords

AMYLOID; MITOCHONDRIAL PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TAU PROTEIN;

ALPHA CHAIN; ALZHEIMER DISEASE; ARTICLE; BRAIN DEGENERATION; CONTROLLED STUDY; CYTOSOL; ENZYME STRUCTURE; HUMAN; HUMAN TISSUE; MITOCHONDRIAL RESPIRATION; MOLECULAR BIOLOGY; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 0037459791     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00747-9     Document Type: Article

References (49)

1. Andersen J.S., Mann M. Functional genomics by mass spectrometry. FEBS Lett. 480:2000;25-31.
2. Bauer M.F., Hofmann S., Neupert W., Brunner M. Protein translocation into mitochondria the role of TIM complexes. Trends Cell Biol. 10:2000;25-31.
3. Beal M.F. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 23:2000;298-304.
4. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl). 82:1991;239-259.
5. Brion J.P., Passareiro H., Nunez J., Flament-Durand J. Immunological detection of tau protein in neurofibrillary tangles of Alzheimer's disease. Arch Biol. 95:1985;229-235.
6. Buee L. Cerebrovascular aging. Therapie. 54:1999;155-165.
7. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev. 33:2000;95-130.
8. Buee-Scherrer V., Condamines O., Mourton-Gilles C., Jakes R., Goedert M., Pau B., Delacourte A. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res. 39:1996;79-88.
9. Busciglio J., Pelsman A., Wong C., Pigino G., Yuan M., Mori H., Yankner B.A. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron. 33:2002;677-688.
10. Cassarino D.S., Bennett J.P. Jr. An evaluation of the role of mitochondria in neurodegenerative diseases mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Brain Res Rev. 29:1999;1-25.
11. Chandrasekaran K., Hatanpaa K., Rapoport S.I., Brady D.R. Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease. Brain Res Mol Brain Res. 44:1997;99-104.
12. Chang S.Y., Park S.G., Kim S., Kang C.Y. Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase its functional implication in endothelial cell proliferation. J Biol Chem. 277:2002;8388-8394.
13. Cho H.S., Hyman B.T., Greenberg S.M., Rebeck G.W. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J Neuropathol Exp Neurol. 60:2001;342-349.
14. Cuezva J.M., Santaren J.F., Gonzalez P., Valcarce C., Luis A.M., Izquierdo J.M. Immunological detection of the mitochondrial F1-ATPase alpha subunit in the matrix of rat liver peroxisomes a protein involved in organelle biogenesis? FEBS Lett. 270:1990;71-75.
15. Das B., Mondragon M.O., Sadeghian M., Hatcher V.B., Norin A.J. A novel ligand in lymphocyte-mediated cytotoxicity expression of the beta subunit of H+ transporting ATP synthase on the surface of tumor cell lines. J Exp Med. 180:1994;273-281.
16. Delacourte A., Defossez A. Alzheimer's disease tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J Neurol Sci. 76:1986;173-186.
17. Delacourte A., David J.P., Sergeant N., Buee L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., Petit H., Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 52:1999;1158-1165.
18. Delacourte A., Sergeant N., Champain D., Wattez A., Maurage C.A., Lebert F., Pasquier F., David J.P. Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. Neurology. 59:2002;398-407.
19. Flores A.I., Cuezva J.M. Identification of sequence similarity between 60 kDa and 70 kDa molecular chaperones evidence for a common evolutionary background? Biochem J. 322:1997;641-647.
20. Gabuzda D., Busciglio J., Chen L.B., Matsudaira P., Yankner B.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem. 269:1994;13623-13628.
21. Garcia-Sierra F., Hauw J.J., Duyckaerts C., Wischik C.M., Luna-Munoz J., Mena R. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old. Acta Neuropathol (Berl). 100:2000;29-35.
22. Glenner G.G., Wong C.W. Alzheimer's disease initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 120:1984;885-890.
23. Godbout R., Pandita A., Beatty B., Bie W., Squire J.A. Comparative genomic hybridization analysis of Y79 and FISH mapping indicate the amplified human mitochondrial ATP synthase alpha-subunit gene (ATP5A) maps to chromosome 18q12->q21. Cytogenet Cell Genet. 77:1997;253-256.
24. Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments abnormal phosphorylation of all six brain isoforms. Neuron. 8:1992;159-168.
25. Greenberg S.G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA. 87:1990;5827-5831.
26. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA. 83:1986;4913-4917.
27. Hensley K., Floyd R.A., Zheng N.Y., Nael R., Robinson K.A., Nguyen X., Pye Q.N., Stewart C.A., Geddes J., Markesbery W.R., Patel E., Johnson G.V., Bing G. p38 kinase is activated in the Alzheimer's disease brain. J Neurochem. 72:1999;2053-2058.
28. Kagawa Y., Ohta S. Regulation of mitochondrial ATP synthesis in mammalian cells by transcriptional control. Int J Biochem. 22:1990;219-229.
29. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
30. Kim S.H., Vlkolinsky R., Cairns N., Lubec G. Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome. Cell Mol Life Sci. 57:2000;1810-1816.
31. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat Med. 6:2000;513-519.
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
33. Ledesma M.D., Da Silva J.S., Crassaerts K., Delacourte A., De Strooper B., Dotti C.G. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep. 1:2000;530-535.
34. Lefebvre-Legendre L., Vaillier J., Benabdelhak H., Velours J., Slonimski P.P., di Rago J.P. Identification of a nuclear gene (FMC1) required for the assembly/stability of yeast mitochondrial F(1)-ATPase in heat stress conditions. J Biol Chem. 276:2001;6789-6796.
35. Lemoine J., Chirat F., Domon B. Structural analysis of derivatized oligosaccharides using post-source decay matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom. 31:1996;908-912.
36. Matsuyama S., Xu Q., Velours J., Reed J.C. The mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell. 1:1998;327-336.
37. Mena R., Edwards P.C., Harrington C.R., Mukaetova-Ladinska E.B., Wischik C.M. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Acta Neuropathol (Berl). 91:1996;633-641.
38. Moser T.L., Stack M.S., Asplin I., Enghild J.J., Hojrup P., Everitt L., Hubchak S., Schnaper H.W., Pizzo S.V. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA. 96:1999;2811-2816.
39. Moser T.L., Kenan D.J., Ashley T.A., Roy J.A., Goodman M.D., Misra U.K., Cheek D.J., Pizzo S.V. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA. 98:2001;6656-6661.
40. Nukina N., Ihara Y. One of the antigenic determinants of paired helical filaments is related to tau protein. J Biochem (Tokyo). 99:1986;1541-1544.
41. O'Farrell P.Z., Goodman H.M., O'Farrell P.H. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell. 12:1977;1133-1141.
42. Permanne B., Buee L., David J.P., Fallet-Bianco C., Di Menza C., Delacourte A. Quantitation of Alzheimer's amyloid peptide and identification of related amyloid proteins by dot-blot immunoassay. Brain Res. 685:1995;154-162.
43. Reig S., Buee-Scherrer V., Mourton-Gilles C., Defossez A., Delacourte A., Beauvillain J.C., Mazzuca M. Immunogold labelling of paired helical filaments and amyloid fibrils by specific monoclonal and polyclonal antibodies. Acta Neuropathol (Berl). 90:1995;441-447.
44. Schagger H., Ohm T.G. Human diseases with defects in oxidative phosphorylation II. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis. Eur J Biochem. 227:1995;916-921.
45. Sergeant N., David J.P., Lefranc D., Vermersch P., Wattez A., Delacourte A. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Lett. 412:1997;578-582.
46. Sergeant N., Sablonniere B., Schraen-Maschke S., Ghestem A., Maurage C.A., Wattez A., Vermersch P., Delacourte A. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet. 10:2001;2143-2155.
47. Sergeant N, David JP, Champain D, Ghestem A, Wattez A, Delacourte A (2002) Progressive decrease of APP carboxy-terminal fragments, associated with tau pathology stages, in Alzheimer's disease. J Neurochem 81:663-672.
48. Vincent I.J., Davies P. A protein kinase associated with paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA. 89:1992;2878-2882.
49. Wood J.G., Mirra S.S., Pollock N.J., Binder L.I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau. Proc Natl Acad Sci USA. 83:1986;4040-4043.